back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-04 19:35 Tx date 2024-03-01 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,387.65
-995 vol $16.47 each |
4,034 | |
| Filed 2024-03-04 19:35 Tx date 2024-03-01 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,323
+2,509 vol $16.47 each |
5,029 | |
| Filed 2024-03-04 19:34 Tx date 2024-03-01 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-41,323.23
-2,509 vol $16.47 each |
53,092 | |
| Filed 2024-03-01 17:14 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+67,114 vol |
100,354 | |
| Filed 2024-03-01 17:14 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+18,182 vol |
33,240 | |
| Filed 2024-03-01 17:13 Tx date 2024-02-28 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+18,183 vol |
55,601 | |
| Filed 2023-07-27 15:51 Tx date 2023-07-25 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-26,023.66
-1,313 vol $19.82 each |
2,520 | |
| Filed 2023-07-27 15:51 Tx date 2023-07-25 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$75,970
+3,833 vol $19.82 each |
3,833 | |
| Filed 2023-07-27 15:50 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-07-27 15:50 Tx date 2023-07-25 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-75,970.06
-3,833 vol $19.82 each |
37,418 | |
| Filed 2023-03-06 15:30 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+15,058 vol |
15,058 | |
| Filed 2023-03-06 15:30 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-06 15:30 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+7,529 vol |
41,251 | |
| Filed 2023-03-06 15:29 Tx date 2023-03-01 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,103 vol |
112,015 | |
| Filed 2022-07-27 22:00 Tx date 2022-07-27 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+11,500 vol |
33,722 | |
| Filed 2022-05-12 08:11 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
87,912 | ||
| Filed 2022-05-12 08:11 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
22,222 | ||
| Filed 2022-03-08 11:15 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,354.88
-608 vol $23.61 each |
10,958 | |
| Filed 2022-03-08 11:14 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,860
+1,773 vol $23.61 each |
11,566 | |
| Filed 2022-03-08 11:13 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,773 vol |
12,224 | |
| Filed 2022-03-03 18:26 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,132.90
-334 vol $24.35 each |
9,793 | |
| Filed 2022-03-03 18:26 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,451.10
-306 vol $24.35 each |
7,141 | |
| Filed 2022-03-03 18:25 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,716
+974 vol $24.35 each |
10,127 | |
| Filed 2022-03-03 18:24 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,695
+891 vol $24.35 each |
7,447 | |
| Filed 2022-03-03 18:24 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-32,093.30
-1,318 vol $24.35 each |
9,153 | |
| Filed 2022-03-03 18:23 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,085
+3,330 vol $24.35 each |
10,471 | |
| Filed 2022-03-03 18:22 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-974 vol |
13,997 | |
| Filed 2022-03-03 18:21 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-891 vol |
14,971 | |
| Filed 2022-03-03 18:19 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,330 vol |
0 | |
| Filed 2022-03-03 18:19 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+3,330 vol |
3,330 | |
| Filed 2022-03-03 18:17 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-05 18:02 Tx date 2021-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,953
+1,246 vol $27.25 each |
15,862 | |
| Filed 2021-06-08 15:09 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
46,672 | ||
| Filed 2021-06-08 15:05 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
14,616 | ||
| Filed 2021-06-08 15:01 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,556 |